ChromaDex (CDXC) Misses Q4 EPS by 1c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/2/2026

1. CRWD
2. REGN
3. LYB
4. CL
5. TFII
6. LITE
7. BP
8. ABBV
9. RELIANCE:I
10. NVT

Go back to ChromaDex (CDXC) Misses Q4 EPS by 1c

ChromaDex Corporation Reports 2020 Financial Results

March 10, 2021 4:02 PM EST

Revenue for the Three-Month Period Ended December 31, 2020 Totals $15.4 Million, up 18% Year-over-Year, with Gross Margin of 61.0%, and Lower Operating Expenses. Full Year Revenue of $59.3 Million, with $47.1 Million from Tru Niagen®.

LOS ANGELES--(BUSINESS WIRE)-- ChromaDex Corp. (NASDAQ: CDXC) today reported fourth quarter and full year 2020 financial results.

Fourth Quarter 2020 and Recent Highlights

Total net sales of $15.4 million, up 18% from $13.1 million in the year ago quarter. Tru Niagen® net sales of $12.3 million, a 21% increase from the year ago quarter. Gross margin... More